癌症研究档案

  • 国际标准期刊号: 2254-6081
  • 期刊 h 指数: 13
  • 期刊引用分数: 3.58
  • 期刊影响因子: 3.12
索引于
  • 中国知网(CNKI)
  • 引用因子
  • OCLC-WorldCat
  • 普布隆斯
  • 日内瓦医学教育与研究基金会
  • 谷歌学术
  • 秘密搜索引擎实验室
分享此页面

抽象的

An Introduction to Immunotherapy in the Treatment of Brain Tumors

Marry Joseph*

A relatively tiny portion of all malignancies in humans are brain cancers. The intricacy and importance of the brain's function, however, result in a high morbidity and death rate for malignancies of the brain. The cerebrospinal fluid and meninges surround the neurons, supporting or glial cells, cranial nerves, glands, and blood arteries that make up the human brain, which is enclosed in a solid skull vault. Each of these cellular components has the potential to become primary brain tumours with different subtypes and levels of aggressiveness. Secondary or metastatic brain malignancies are increasingly common as a result of better control of more common cancers such breast, lung, and colon. The biology of the malignancy is the primary determinant of the clinical consequences of a brain tumour. The tumor's location and its ability to receive treatment with little side effect come next. Size, vascularity, peri-tumoral edoema, and adverse effects of treatments on the nearby normal brain are other significant factors.

Keywords

Brain; Cancer; Health care; Neuroscience